RITONAVIR (NORVIR¸ FORMERLY ABT-538)

a protease inhibitor drug approved for the treatment of HIV disease. Current practice favors the use of ritonavir in combination therapy (e.g., with nucleoside analog drugs) to avoid the development of drug-resistant virus.